Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 23, 2008
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors
Jill Kolesar, Wei Huang, Jens Eickhoff, et al.
Surgical Oncology
|
August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Nathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
Targeted Oncology
|
April 24, 2021
Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy
Oluwaseun O Akinduro, Paola Suarez-Meade, Diogo Garcia, et al.
Investigational New Drugs
|
February 19, 2008
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas
Steven Attia, Jill Kolesar, Michelle R Mahoney, et al.
Journal of Geriatric Oncology
|
May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
Eugenie Younger, Karla Ballman, Yao Lu, et al.
Cancers
|
February 13, 2026
Multi-Targeted TKIs in Patients with Advanced Ewing Sarcoma: A Systematic Review and Single-Arm Meta-Analysis
Isabella Michelon, Caio Ernesto do Rêgo Castro, Ana Paula Querino Belluco, et al.
Cancers
|
October 14, 2023
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas
Steven Attia, Victor Villalobos, Nadia Hindi, et al.
Cancer
|
July 10, 2024
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma
Gregory M Cote, Anthony P Conley, Steven Attia, et al.
Cancer Chemotherapy and Pharmacology
|
September 22, 2007
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
Howard H Bailey, Steven Attia, Richard R Love, et al.
Journal of Oncology Practice
|
July 4, 2019
Incidence and Management of Olaratumab Infusion-Related Reactions
Brian A Van Tine, Rangaswamy Govindarajan, Steven Attia, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Cancer Chemotherapy and Pharmacology
|
October 23, 2008
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors
Jill Kolesar, Wei Huang, Jens Eickhoff, et al.
Surgical Oncology
|
August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Nathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
Targeted Oncology
|
April 24, 2021
Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy
Oluwaseun O Akinduro, Paola Suarez-Meade, Diogo Garcia, et al.
Investigational New Drugs
|
February 19, 2008
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas
Steven Attia, Jill Kolesar, Michelle R Mahoney, et al.
Journal of Geriatric Oncology
|
May 26, 2019
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
Eugenie Younger, Karla Ballman, Yao Lu, et al.
Cancers
|
February 13, 2026
Multi-Targeted TKIs in Patients with Advanced Ewing Sarcoma: A Systematic Review and Single-Arm Meta-Analysis
Isabella Michelon, Caio Ernesto do Rêgo Castro, Ana Paula Querino Belluco, et al.
Cancers
|
October 14, 2023
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas
Steven Attia, Victor Villalobos, Nadia Hindi, et al.
Cancer
|
July 10, 2024
A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma
Gregory M Cote, Anthony P Conley, Steven Attia, et al.
Cancer Chemotherapy and Pharmacology
|
September 22, 2007
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer
Howard H Bailey, Steven Attia, Richard R Love, et al.
Journal of Oncology Practice
|
July 4, 2019
Incidence and Management of Olaratumab Infusion-Related Reactions
Brian A Van Tine, Rangaswamy Govindarajan, Steven Attia, et al.
Page
of 8